Evidence map›Paper›PMID 32596281›Full record

ArticleBioMed research international2020

Employment of Alginate Floating

Bazigha K Abdul Rasool, AlZahraa Khalifa, Eman Abu-Gharbieh, Rawoof Khan

Abstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bazigha K Abdul RasoolPharmaceutics Department, Dubai Pharmacy College for Girls, Dubai, UAE.ORCID https://orcid.org/0000-0003-3187-1485
AlZahraa KhalifaPharmaceutics Department, Dubai Pharmacy College for Girls, Dubai, UAE.
Eman Abu-GharbiehClinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, UAE.ORCID https://orcid.org/0000-0002-5972-0681
Rawoof KhanDubai Institute for Environmental Research and Laboratory Analysis, Dubai, UAE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Celecoxib (CXB) is a COX-2-selective nonsteroidal anti-inflammatory drug used to control pain and various inflammatory conditions. CXB has limited oral bioavailability and a slow dissociation rate due to its poor water solubility. In order to enhance the oral bioavailability of CXB and reduce the frequency of administration, the present study was aimed at enhancing the aqueous solubility of CXB by a cosolvency technique and then at formulating and evaluating a CXB

Indexed as

Anti-Inflammatory Agents, Non-SteroidalCelecoxibAlginatesAnimalsBehavior, AnimalBiological AvailabilityDelayed-Action PreparationsDrug Delivery SystemsEdemaFemaleHindlimbMaleRatsRats, WistarSolubilityAlginatesAnti-Inflammatory Agents, Non-SteroidalCelecoxibDelayed-Action Preparations

Identifiers

PMID32596281
PMCPMC7296469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.